Tom Miller, Iambic CEO and co-founder, joins 'Fast Money' to talk how his company is disrupting the clinical trial space ...
Pharmaceutical Technology on MSN

QIAGEN and NVIDIA partner on AI drug discovery

The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
We know the scientific method to be sequential and empirical: Ask, observe, hypothesize. Test, analyze, report. And then do it all over again, and again, and again. For better or worse, that sequence ...
Two artificial intelligence (AI) systems that can assist throughout multiple processes involved in scientific research—such ...
Conventional drug delivery is known for being both a lengthy and expensive process, with pre-clinical testing taking between three to six years and costing between hundreds of millions of dollars to ...
Artificial Intelligence (AI) and machine learning are transforming the worlds of biotechnology and pharma, particularly in the arena of drug discovery. Leveraging the rise of large datasets and ...
Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...
Surface plasmon resonance (SPR) offers researchers a powerful way to observe molecular interactions directly, measuring binding events with exceptional sensitivity and without fluorescent or chemical ...
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...